Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

Pancreatic cancer is a complex and deadly solid tumor that poses significant challenges for both diagnosis and treatment. It is known for its aggressive local invasion and tendency for distant metastases, resulting in around 227,000 fatalities worldwide each year.